<it>Ex vivo </it>activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of <it>Plasmodium falciparum</it>

<it>Ex vivo </it>activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of <it>Plasmodium falciparum</it>

<p>Abstract</p> <p>Background</p> <p>The aim of the present work was to assess i) <it>ex vivo </it>activity of pyronaridine (PND) and piperaquine (PPQ), as new components of artemisinin-based combination therapy (ACT), to define susceptibility baseline, ii)...

Full description

Bibliographic Details
Main Authors: Pascual Aurélie, Parola Philippe, Benoit-Vical Françoise, Simon Fabrice, Malvy Denis, Picot Stéphane, Delaunay Pascal, Basset Didier, Maubon Danièle, Faugère Bernard, Ménard Guillaume, Bourgeois Nathalie, Oeuvray Claude, Didillon Eric, Rogier Christophe, Pradines Bruno
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Malaria Journal
Subjects:
Malaria
<it>Plasmodium falciparum</it>
Anti-malarial
<it>In vitro</it>
Resistance
Pyronaridine
Piperaquine
Online Access:http://www.malariajournal.com/content/11/1/45

Internet

http://www.malariajournal.com/content/11/1/45

Similar Items